Corporate Office Level 10, 10 Queen Street Melbourne, Victoria, 3000, Australia +61 3 9620 0250 SEND US A MESSAGE Telephone: +61 3 9620 0250 Email: [email protected] Website: curvebeamai.com Global Operations Headquarters 2800 Bronze Dr., Suite 110 Hatfield, PA 19440 USA ASX ANNOUNCEMENT ...
Q1 FY27 Quarterly Results Investor Webinar
Filed with ASX · · 1 page · English
Summary by 6ix AI
Curvebeam AI Ltd. is hosting an investor webinar to discuss its recent announcements and quarterly results. The webinar will cover the FDA clearance for its Bone Mineral Density technology and NMPA approval for HiRise™ in China. CEO Greg Brown will present and answer questions from investors during the session. The company develops specialized medical imaging equipment and AI solutions for musculoskeletal conditions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Story so far
Earlier from CurveBeam AI
- Change in substantial holding - Intellivision Holdings
- Change in substantial holding - Arun & Susmita Singh
- CVB Achieves NMPA Approval for HiRise in China
- Trading Halt
- Cleaning Notice for Shortfall Overflow Placement - Part B
Later from CurveBeam AI
- Quarterly Activities/Appendix 4C Cash Flow Report
- CVB Quarterly Investor Presentation - Q1 FY27
- Director Appointment - Dan Pryor NED & ARC Chair
- Notification regarding unquoted securities - CVB
- Initial Director's Interest Notice - Dan Pryor
Follow CurveBeam AI into a list and get an email when it puts out news.
Follow CurveBeam AI